Evidence map›Paper›PMID 41868808›Full record

ArticlePeerJ2026

Effect of growth hormone adjuvant treatment on oocyte retrieval in patients with poor ovarian response and no viable embryos in previous

Liang Gao, Yuting Zhang, Mengyun Li, Jingyu Zhang, Jianjun Zhou

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in PeerJ, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Liang Gao *Drum Tower Clinic Medical College of Nanjing Medical University, Nanjing, China.
Yuting Zhang *Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
Mengyun LiNanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
Jingyu ZhangNanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
Jianjun ZhouDrum Tower Clinic Medical College of Nanjing Medical University, Nanjing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: This study aimed to evaluate the efficacy of growth hormone (GH) as an adjuvant treatment for enhancing embryo quantity in patients with poor ovarian response (POR) who previously had no viable embryos in in vitro fertilization (IVF) cycles. Methods: A total of 86 POR patients with no viable embryos in their first IVF cycles were enrolled. Among them, 43 patients in the study group received GH adjuvant treatment during their second IVF cycle, while the remaining 43 patients in the control group did not receive GH. Clinical characteristics were compared between the GH+ and GH- cycles within the study group, and further comparisons were made between the study and control groups regarding clinical characteristics and IVF outcomes. Results: Self-controlled analysis showed that GH adjuvant treatment significantly increased the number of oocytes retrieved ( Conclusion: GH adjuvant treatment may improve the number of oocytes retrieved in POR patients who previously had no viable embryos in IVF cycles.

Indexed as

Fertilization in VitroGrowth HormoneOocyte RetrievalOvulation InductionAdultEmbryo TransferFemaleHumansLuteinizing HormonePregnancyGrowth HormoneLuteinizing HormoneGrowth hormoneLuteinizing hormonePoor ovarian responseTransferable embryo

Identifiers

PMID41868808
PMCPMC13001661

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.